Clinical Trials Browser

Head and Neck Neoplasms × dostarlimab × Gastrointestinal × Clear all

NCT04779151 2025-12-01

NIRADO

Phase 2 Terminated

GastrointestinalGenitourinaryHead & Neck

Biliary Tract Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms